Drug Safety During Pregnancy: General Principles Every Expectant Patient Should Know

Why Medication Safety Is Different During Pregnancy

Pregnancy changes nearly every system in the body — including how drugs are absorbed, distributed, metabolized, and eliminated. Blood volume increases, kidney filtration speeds up, and liver enzyme activity shifts. These physiological changes can alter how effective or how concentrated a medication becomes in your body.

More critically, many medications are able to cross the placenta and enter fetal circulation. Because a developing fetus has immature organ systems and cannot metabolize drugs the way an adult can, substances that are well-tolerated by the mother may accumulate in fetal tissue or disrupt normal development. The risk depends on the type of drug, the dose, and the gestational age at exposure.

This is why pregnancy is considered a special population in drug safety — and why providers and pharmacists apply heightened caution to any medication decision during this time. As with common medication misconceptions, assuming a drug is safe simply because it is familiar or widely used can be misleading when pregnancy changes the equation.

How the FDA Classifies Drug Risk in Pregnancy

For decades, the FDA used a letter-based system — categories A, B, C, D, and X — to signal the level of risk a medication posed during pregnancy. While widely used, this system was criticized for oversimplifying complex risk profiles into a single letter grade.

In 2015, the FDA implemented the Pregnancy and Lactation Labeling Rule (PLLR), which requires drug manufacturers to include structured, narrative risk summaries in prescribing information. These summaries draw on available human clinical data, animal studies, and known pharmacological mechanisms to describe the nature and magnitude of risk — rather than reducing it to a letter.

Under PLLR, labeling includes three subsections: Pregnancy (risk to the fetus), Lactation (risk during breastfeeding), and Females and Males of Reproductive Potential (effects on fertility and contraception needs). This level of detail gives providers a more complete picture when counseling patients.

High-Risk Windows and Why Timing Matters

Not all stages of pregnancy carry equal risk. The embryonic period — roughly the third through eighth week after conception — is when the fetus's major organ systems are forming. Exposure to certain medications or toxic substances during this window carries the greatest potential for structural birth defects, known as teratogenesis.

Later in pregnancy, risks shift. Some medications taken in the second or third trimester have been associated with effects on fetal kidney development, premature closure of certain cardiac structures, or neonatal withdrawal symptoms after birth. This means that a drug considered lower-risk early in pregnancy may be more concerning in the third trimester — and vice versa.

Understanding this timeline helps explain why your provider's medication guidance may change across your pregnancy. It also underscores why reporting a new or changed medication to your care team promptly is important, especially if you are managing a chronic condition that requires ongoing treatment.

Practical Steps for Safer Medication Use While Pregnant

The most important principle is straightforward: no medication decision during pregnancy should be made without input from a qualified healthcare provider. This includes prescription drugs, over-the-counter products, vitamins, and herbal supplements. Many supplements — including some marketed specifically for pregnancy — have not been rigorously tested for safety in this population.

Before your next prenatal appointment, compile a complete list of everything you are taking. Your pharmacist can be a valuable first point of contact for questions about specific drugs, potential interactions, and safer alternatives. For a practical framework on how to approach these conversations, see questions to ask your pharmacist before starting a new medication.

Also be aware that drug interactions remain a risk during pregnancy. The same principles that make combining certain medications dangerous in the general population apply here — with added stakes. Our overview of how two safe medicines can become dangerous together explains the underlying mechanisms. Finally, don't overlook other aspects of your health — oral health during pregnancy is another area where treatment decisions, including medications like local anesthetics, require extra care.

This article is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your obstetrician, midwife, or pharmacist before taking, stopping, or changing any medication during pregnancy.